Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Kerneis

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Archives of Cardiovascular Diseases|August 28, 2023
Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditisMathieu Kerneis, Fleur Cohen, Alain Combes, et al.
European Journal of Clinical Pharmacology|August 13, 2015
Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE studyJean-Philippe Collet, Jean-Sébastien Hulot, Thomas Cuisset, et al.
Circulation. Cardiovascular Interventions|February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Efficacy and Safety of Intravenous Antiplatelet Therapy in Acute Myocardial Infarction With Cardiogenic ShockAnthony Elhadad, Omar El Zouhayri, Johanne Silvain, et al.
American Heart Journal|July 18, 2018
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trialGerald Chi, Mathieu Kerneis, Arzu Kalayci, et al.
Nature Communications|January 11, 2022
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance databaseLee S Nguyen, Leslie T Cooper, Mathieu Kerneis, et al.
The New England Journal of Medicine|September 1, 2025
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral AnticoagulationGilles Lemesle, Romain Didier, Philippe Gabriel Steg, et al.
JACC. Advances|July 29, 2025
Feasibility and Prognostic Value of Stress Cardiovascular Magnetic Resonance in Patients With End-Stage Renal DiseaseIyad Rifai, Saida Ourahma, Thomas Ki-Yong Broussaud, et al.
Circulation|February 26, 2019
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill PatientsTarek Nafee, C Michael Gibson, Megan K Yee, et al.
European Journal of Preventive Cardiology|November 7, 2024
Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular eventJohanne Silvain, Clément Materne, Michel Zeitouni, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Archives of Cardiovascular Diseases|August 28, 2023
Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditisMathieu Kerneis, Fleur Cohen, Alain Combes, et al.
European Journal of Clinical Pharmacology|August 13, 2015
Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE studyJean-Philippe Collet, Jean-Sébastien Hulot, Thomas Cuisset, et al.
Circulation. Cardiovascular Interventions|February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Efficacy and Safety of Intravenous Antiplatelet Therapy in Acute Myocardial Infarction With Cardiogenic ShockAnthony Elhadad, Omar El Zouhayri, Johanne Silvain, et al.
American Heart Journal|July 18, 2018
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trialGerald Chi, Mathieu Kerneis, Arzu Kalayci, et al.
Nature Communications|January 11, 2022
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance databaseLee S Nguyen, Leslie T Cooper, Mathieu Kerneis, et al.
The New England Journal of Medicine|September 1, 2025
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral AnticoagulationGilles Lemesle, Romain Didier, Philippe Gabriel Steg, et al.
JACC. Advances|July 29, 2025
Feasibility and Prognostic Value of Stress Cardiovascular Magnetic Resonance in Patients With End-Stage Renal DiseaseIyad Rifai, Saida Ourahma, Thomas Ki-Yong Broussaud, et al.
Circulation|February 26, 2019
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill PatientsTarek Nafee, C Michael Gibson, Megan K Yee, et al.
European Journal of Preventive Cardiology|November 7, 2024
Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular eventJohanne Silvain, Clément Materne, Michel Zeitouni, et al.
Pageof 15